KM Financial Solutions | MOVES-China’s Hua Medicine appoints BAML banker as new CFO ahead of listing
6185
post-template-default,single,single-post,postid-6185,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

MOVES-China’s Hua Medicine appoints BAML banker as new CFO ahead of listing

MOVES-China’s Hua Medicine appoints BAML banker as new CFO ahead of listing

HONG KONG, Dec 22 (Reuters) – Chinese drug developer Hua
Medicine has appointed George Lin, a veteran Bank of America
Merrill Lynch banker as its chief financial officer, as
it seeks to go public in the next 12 to 18 months.

No Comments

Sorry, the comment form is closed at this time.